US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist

8.670
+0.360+4.33%

Close Nov 1 16:00 ET

8.670
0.0000.00%

Post 20:01 ET

1.01BMarket Cap-5100P/E (TTM)

Arcutis Biotherapeutics Stock Forum

MommaCrazy

Oct 22 18:50

$Arcutis Biotherapeutics (ARQT.US)$ Blackrock bought over 9mil shares today.

MommaCrazy

Oct 20 20:26

$Arcutis Biotherapeutics (ARQT.US)$ This should rebound in the morning. 🙏
Long-term! 😜

Trytosaveabit

Oct 18 07:21

News

$Arcutis Biotherapeutics (ARQT.US)$ Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older
1 MINUTE AGO, 8:20 AM EDT
VIA GLOBENEWSWIRE

Rocketier

Oct 3 13:14

$Arcutis Biotherapeutics (ARQT.US)$ Shorts will suffer

Teddy123

Sep 25 00:03

New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types

$Arcutis Biotherapeutics (ARQT.US)$
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types | ARQT Stock News

demonandevil

Sep 4 09:59

$Arcutis Biotherapeutics (ARQT.US)$ keep testing high

demonandevil

Aug 29 09:49

$Arcutis Biotherapeutics (ARQT.US)$ 11 , going to moon

Trytosaveabit

Aug 28 07:21

Update

$Arcutis Biotherapeutics (ARQT.US)$ Arcutis Biotherapeutics Inc -No New Safety Signals Observed During 56 Weeks of Treatment! Plans to submit sNDA to FDA in Q1 2025